Market revenue in 2023 | USD 293.5 million |
Market revenue in 2030 | USD 518.3 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Type a |
Fastest growing segment | Type A |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Type A, Type B |
Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.64% in 2023. Horizon Databook has segmented the Italy botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
Italy ranked third in the world in terms of the number of nonsurgical esthetic procedures undertaken in 2019. It accounted for about 5.9% of all cosmetic minimally invasive procedures performed worldwide, which highlights the high market demand. Increasing esthetic consciousness is boosting demand and popularity of cosmetic procedures in the country.
According to International Society of Plastic Surgery, in 2021, approximately 317,880 injectable procedures, of which 129,720 were BoNT injections. Statistics also suggest that consumer interest in minimally invasive cosmetic procedures outpaced interest in surgical treatments in 2019.
Technological advancements and availability of a large number of plastic surgeons have resulted in improved accessibility to esthetic procedures. For instance, as of 2021, the total number of esthetic surgeons in the country accounted for 2.8% (1,390) of the total surgeons globally, thereby fueling the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into Italy botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account